. There is increased white (opacity) in the lower lungs on both sides, characteristic of PCP. The symptoms of AIDS are primarily the result of conditions that do not normally develop in individuals with healthy
immune systems. Most of these conditions are
opportunistic infections caused by bacteria, viruses,
fungi, and
parasites that are normally controlled by the elements of the immune system that HIV damages. These infections affect nearly every
organ system. A declining
CD4+/CD8+ ratio is predictive of the progression of HIV to AIDS. People with AIDS also have an increased risk of developing various cancers such as
Kaposi's sarcoma,
cervical cancer, and cancers of the immune system known as
lymphomas. Additionally, people with AIDS often have systemic symptoms of infection like fevers,
sweats (particularly at night), swollen glands, chills, weakness, and
weight loss. The specific opportunistic infections that AIDS patients develop depend in part on the prevalence of these infections in the geographic area in which the patient lives.
Pulmonary Pneumocystis pneumonia (PCP) (originally known as
Pneumocystis carinii pneumonia) is relatively rare in healthy,
immunocompetent people, but common among HIV-infected individuals. It is caused by
Pneumocystis jirovecii. Before the advent of effective diagnosis, treatment, and routine
prophylaxis in Western countries, it was a common immediate cause of death. In developing countries, it is still one of the first indications of AIDS in untested individuals, although it does not generally occur unless the CD4 count is less than 200 cells per μL of blood.
Tuberculosis (TB) is unique among infections associated with HIV because it is transmissible to immunocompetent people via the respiratory route, and it is not easily treatable once identified.
Multidrug resistance is a serious problem.
Tuberculosis with HIV co-infection (TB/HIV) is a major world health problem according to the
World Health Organization: in 2007, 456,000 deaths among incident TB cases were HIV-positive, a third of all TB deaths and nearly a quarter of the estimated 2 million HIV deaths in that year. Even though its incidence has declined because of the use of directly observed therapy and other improved practices in Western countries, this is not the case in developing countries where HIV is most prevalent. In early-stage HIV infection (CD4 count >300 cells per μL), TB typically presents as a pulmonary disease. In advanced HIV infection, TB often presents atypically with extrapulmonary (systemic) disease a common feature. Symptoms are usually constitutional and are not localized to one particular site, often affecting
bone marrow,
bone, urinary and
gastrointestinal tracts,
liver, regional
lymph nodes, and the
central nervous system.
Gastrointestinal Esophagitis is an inflammation of the lining of the lower end of the
esophagus (gullet or swallowing tube leading to the
stomach). In HIV-infected individuals, this is normally due to fungal (
candidiasis) or viral (
herpes simplex-1 or
cytomegalovirus) infections. In rare cases, it could be due to
mycobacteria. Unexplained chronic
diarrhea in HIV infection is due to many possible causes, including common bacterial (
Salmonella,
Shigella,
Listeria or
Campylobacter) and parasitic infections; and uncommon opportunistic infections such as
cryptosporidiosis,
microsporidiosis,
Mycobacterium avium complex (MAC) and viruses,
astrovirus,
adenovirus,
rotavirus and
cytomegalovirus, (the latter as a course of
colitis). In some cases, diarrhea may be a side effect of several drugs used to treat HIV, or it may simply accompany HIV infection, particularly during primary HIV infection. It may also be a side effect of
antibiotics used to treat bacterial causes of diarrhea (common for
Clostridioides difficile). In the later stages of HIV infection, diarrhea is thought to be a reflection of changes in the way the
intestinal tract absorbs nutrients and may be an important component of HIV-related
wasting.
Neurological and psychiatric HIV infection may lead to a variety of neuropsychiatric
sequelae, either by infection of the now susceptible nervous system by organisms, or as a direct consequence of the illness itself.
Toxoplasmosis is a disease caused by the single-celled
parasite Toxoplasma gondii; it usually infects the brain, causing toxoplasma
encephalitis, but it can also infect and cause disease in the
eyes and lungs. Cryptococcal meningitis is an infection of the
meninx (the membrane covering the brain and
spinal cord) by the fungus
Cryptococcus neoformans. It can cause fevers, headache,
fatigue,
nausea, and vomiting. Patients may also develop
seizures and confusion; left untreated, it can be lethal.
Progressive multifocal leukoencephalopathy (PML) is a
demyelinating disease, in which the gradual destruction of the
myelin sheath covering the
axons of nerve cells impairs the transmission of nerve impulses. It is caused by a virus called
JC virus which occurs in 70% of the population in
latent form, causing disease only when the immune system has been severely weakened, as is the case for AIDS patients. It progresses rapidly, usually causing death within months of diagnosis.
HIV-associated dementia (HAD) is a metabolic
encephalopathy induced by HIV infection and fueled by immune activation of HIV-infected brain
macrophages and
microglia. These cells are productively infected by HIV and secrete
neurotoxins of both host and viral origin. Specific neurological impairments are manifested by cognitive, behavioral, and motor abnormalities that occur after years of HIV infection and are associated with low CD4+ T cell levels and high plasma viral loads. Prevalence is 10–20% in Western countries but only 1–2% of HIV infections in India. This difference is possibly due to the HIV subtype in India. AIDS-related mania is sometimes seen in patients with advanced HIV illness; it presents with more irritability and cognitive impairment and less euphoria than a
manic episode associated with true
bipolar disorder. Unlike the latter condition, it may have a more chronic course. This syndrome is less frequently seen with the advent of multi-drug therapy.
Tumors People with HIV infections have substantially increased incidence of several cancers. This is primarily due to co-infection with an
oncogenic DNA virus, especially
Epstein-Barr virus (EBV),
Kaposi's sarcoma-associated herpesvirus (KSHV) (also known as human herpesvirus-8 [HHV-8]), and
human papillomavirus (HPV). Kaposi's sarcoma (KS) is the most common tumor in HIV-infected patients. The appearance of this tumor in young
homosexual men in 1981 was one of the first signals of the AIDS epidemic. Caused by a
gammaherpes virus called
Kaposi's sarcoma-associated herpes virus (KSHV), it often appears as purplish
nodules on the skin, but can affect other organs, especially the mouth, gastrointestinal tract, and lungs. High-grade
B cell lymphomas such as
Burkitt's lymphoma, Burkitt's-like lymphoma, diffuse large B-cell lymphoma (DLBCL), and
primary central nervous system lymphoma present more often in HIV-infected patients. These particular cancers often foreshadow a poor prognosis.
Epstein-Barr virus (EBV) or KSHV cause many of these lymphomas. In HIV-infected patients, lymphoma often arises in extranodal sites such as the gastrointestinal tract. When they occur in an HIV-infected patient, KS and aggressive B cell lymphomas confer a diagnosis of AIDS. Invasive
cervical cancer in HIV-infected women is also considered AIDS-defining; it is caused by
human papillomavirus (HPV). In addition to the AIDS-defining tumors listed above, HIV-infected patients are at increased risk of certain other tumors, notably
Hodgkin's disease,
anal and
rectal carcinomas,
hepatocellular carcinomas,
head and neck cancers, and lung cancer. Some of these are caused by viruses, such as Hodgkin's disease (EBV), anal/rectal cancers (HPV), head and neck cancers (HPV), and hepatocellular carcinoma (
hepatitis B or
C). Other contributing factors include exposure to carcinogens (cigarette smoke for lung cancer), or living for years with subtle immune defects. The incidence of many common tumors, such as
breast cancer or
colon cancer, does not increase in HIV-infected patients. In areas where
HAART is extensively used to treat AIDS, the incidence of many AIDS-related malignancies has decreased, but at the same time malignant cancers overall have become the most common cause of death of HIV-infected patients. In recent years, an increasing proportion of these deaths have been from non-AIDS-defining cancers. In line with the treatment of cancer, chemotherapy has shown promise in increasing the number of uninfected T-cells and diminishing the viral load.
Other infections People with AIDS often develop opportunistic infections that present with
non-specific symptoms, especially
low-grade fevers and weight loss. These include opportunistic infection with
Mycobacterium avium-intracellulare and
cytomegalovirus (CMV). CMV can cause colitis, as described above, and
CMV retinitis can cause blindness.
Talaromycosis due to
Talaromyces marneffei is now the third most common opportunistic infection (after extrapulmonary tuberculosis and
cryptococcosis) in HIV-positive individuals within the endemic area of Southeast Asia. An infection that often goes unrecognized in people with AIDS is
Parvovirus B19. Its main consequence is
anemia, which is difficult to distinguish from the effects of antiretroviral drugs used to treat AIDS itself. ==References==